Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Loda

Showing results (291-300 of 409) with videos related to

Pageof 41
Sort By:
Science (New York, N.Y.)|January 7, 2017
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistanceSheng Yu Ku, Spencer Rosario, Yanqing Wang, et al.
Carcinogenesis|June 26, 2010
Genetic variation in RNASEL associated with prostate cancer risk and progressionMara S Meyer, Kathryn L Penney, Jennifer R Stark, et al.
Nature Genetics|October 13, 2015
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisMark M Pomerantz, Fugen Li, David Y Takeda, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
MYC regulation of a "poor-prognosis" metastatic cancer cell stateAnita Wolfer, Ben S Wittner, Daniel Irimia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2013
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective studyKe Zu, Neil E Martin, Michelangelo Fiorentino, et al.
Molecular Cell|September 24, 2021
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesisJuan F Linares, Xiao Zhang, Anxo Martinez-Ordoñez, et al.
The Prostate|March 3, 2015
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancerRebecca E Graff, Andreas Pettersson, Rosina T Lis, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate CancerArwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.
European Urology|September 2, 2023
Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer ProgressionAlexandros Papachristodoulou, Isabel Heidegger, Renu K Virk, et al.
Molecular Cancer Therapeutics|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Pageof 41

Showing results (291-300 of 409) with videos related to

Sort By:
Pageof 41
Science (New York, N.Y.)|January 7, 2017
Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistanceSheng Yu Ku, Spencer Rosario, Yanqing Wang, et al.
Carcinogenesis|June 26, 2010
Genetic variation in RNASEL associated with prostate cancer risk and progressionMara S Meyer, Kathryn L Penney, Jennifer R Stark, et al.
Nature Genetics|October 13, 2015
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisMark M Pomerantz, Fugen Li, David Y Takeda, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
MYC regulation of a "poor-prognosis" metastatic cancer cell stateAnita Wolfer, Ben S Wittner, Daniel Irimia, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 29, 2013
Protein expression of PTEN, insulin-like growth factor I receptor (IGF-IR), and lethal prostate cancer: a prospective studyKe Zu, Neil E Martin, Michelangelo Fiorentino, et al.
Molecular Cell|September 24, 2021
PKCλ/ι inhibition activates an ULK2-mediated interferon response to repress tumorigenesisJuan F Linares, Xiao Zhang, Anxo Martinez-Ordoñez, et al.
The Prostate|March 3, 2015
The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancerRebecca E Graff, Andreas Pettersson, Rosina T Lis, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate CancerArwa Fallatah, Stefan DiFazio, Lakshmi Ravindranath, et al.
European Urology|September 2, 2023
Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer ProgressionAlexandros Papachristodoulou, Isabel Heidegger, Renu K Virk, et al.
Molecular Cancer Therapeutics|November 3, 2022
The AACR Journals: Advancing Progress Toward the AACR's 115-Year MissionKenneth C Anderson, Lewis C Cantley, Riccardo Dalla-Favera, et al.
Pageof 41